New vaccine, long-acting drug trials buoy hopes in HIV fight


Researchers announced the launch of two big studies in Africa on Thursday to test a new HIV vaccine and a long-acting injectable drug, fueling hopes for better ways to protect against the virus that causes AIDS. The start of the three-year vaccine trial involving 2,600 women in southern Africa means that for the first time in more than a decade there are now two big HIV vaccine clinical trials taking place at the same time.



from Biotech News